INTECH Investment Management’s Maravai LifeSciences MRVI Stock Holding History

INTECH Investment Management’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$80.2K	Sell	28,342 -25,860	-48%	-$87.7K	﹤0.01%	1935
2025 Q4	$176K	Sell	54,202 -7,219	-12%	-$24.3K	﹤0.01%	2028
2025 Q3	$176K	Sell	61,421 -10,744	-15%	-$27.4K	﹤0.01%	2112
2025 Q2	$174K	Sell	72,165 -13,424	-16%	-$28.2K	﹤0.01%	2135
2025 Q1	$189K	Buy	85,589 +35,909	+72%	+$142K	﹤0.01%	2115
2024 Q4	$271K	Buy	49,680 +25,668	+107%	+$165K	﹤0.01%	1882
2024 Q3	$200K	Buy	+24,012	New	+$208K	﹤0.01%	1720
2023 Q3	–	Sell	-14,113	Closed	-$175K	–	744
2023 Q2	$175K	Buy	+14,113	New	+$190K	﹤0.01%	698

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

INTECH Investment Management's MRVI Position: Q1 2026 in Review

INTECH Investment Management reduced its Maravai LifeSciences (MRVI) stake by 48% in Q1 2026, selling an estimated $87.7K and leaving 28,342 shares worth $80.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1935.

INTECH Investment Management first reported a position in MRVI in Q2 2023 and has held it in 8 quarters since. The position peaked at $271K in Q4 2024. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

INTECH Investment Management held 28,342 shares of Maravai LifeSciences worth $80.2K as of Q1 2026.
INTECH Investment Management sold 25,860 Maravai LifeSciences shares in Q1 2026, an estimated $87.7K.
Maravai LifeSciences made up ﹤0.01% of INTECH Investment Management's portfolio in Q1 2026, its #1935 holding.
INTECH Investment Management first reported a position in Maravai LifeSciences in Q2 2023 and has held it in 8 quarters since.
INTECH Investment Management's Maravai LifeSciences position peaked at $271K in Q4 2024.
158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.